| Year |
Citation |
Score |
| 2012 |
Mondo K, Hammerschlag N, Basile M, Pablo J, Banack SA, Mash DC. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Marine Drugs. 10: 509-20. PMID 22412816 DOI: 10.3390/Md10020509 |
0.476 |
|
| 2010 |
Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae. 9: 620-635. PMID 21057660 DOI: 10.1016/J.Hal.2010.05.002 |
0.491 |
|
| 2009 |
Mash DC, Duque L, Pablo J, Qin Y, Adi N, Hearn WL, Hyma BA, Karch SB, Druid H, Wetli CV. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Science International. 190: e13-9. PMID 19541436 DOI: 10.1016/J.Forsciint.2009.05.012 |
0.539 |
|
| 2009 |
Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, Buck A, Mash DC. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurologica Scandinavica. 120: 216-25. PMID 19254284 DOI: 10.1111/J.1600-0404.2008.01150.X |
0.49 |
|
| 2008 |
Mash DC, Adi N, Duque L, Pablo J, Kumar M, Ervin FR. Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and Alcohol Dependence. 94: 246-50. PMID 18055133 DOI: 10.1016/J.Drugalcdep.2007.09.020 |
0.563 |
|
| 2007 |
Mash DC, ffrench-Mullen J, Adi N, Qin Y, Buck A, Pablo J. Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. Plos One. 2: e1187. PMID 18000554 DOI: 10.1371/Journal.Pone.0001187 |
0.565 |
|
| 2006 |
Papapetropoulos S, Ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, Mash DC. Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. Gene Expression. 13: 205-15. PMID 17193926 DOI: 10.3727/000000006783991827 |
0.483 |
|
| 2005 |
Qin Y, Ouyang Q, Pablo J, Mash DC. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport. 16: 1489-93. PMID 16110277 DOI: 10.1097/01.Wnr.0000175617.39054.Ba |
0.569 |
|
| 2005 |
Mash DC, Ouyang Q, Qin Y, Pablo J. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. Journal of Neuroscience Methods. 143: 79-85. PMID 15763139 DOI: 10.1016/J.Jneumeth.2004.09.013 |
0.588 |
|
| 2003 |
Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2564-71. PMID 12684441 |
0.527 |
|
| 2003 |
Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons The Journal of Neuroscience. 23: 2564-2571. DOI: 10.1523/Jneurosci.23-07-02564.2003 |
0.566 |
|
| 2002 |
Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. Journal of Neurochemistry. 81: 292-300. PMID 12064476 DOI: 10.1046/J.1471-4159.2002.00820.X |
0.6 |
|
| 2001 |
Baumann MH, Pablo J, Ali SF, Rothman RB, Mash DC. Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine Alkaloids: Chemistry and Biology. 56: 79-113. PMID 11705118 DOI: 10.1016/S0099-9598(01)56009-5 |
0.574 |
|
| 2001 |
Mash DC, Kovera CA, Pablo J, Tyndale R, Ervin FR, Kamlet JD, Hearn WL. Ibogaine in the treatment of heroin withdrawal. The Alkaloids. Chemistry and Biology. 56: 155-71. PMID 11705106 DOI: 10.1016/S0099-9598(01)56012-5 |
0.518 |
|
| 2001 |
Baumann MH, Rothman RB, Pablo JP, Mash DC. In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 531-9. PMID 11303040 |
0.492 |
|
| 2000 |
Mash DC, Kovera CA, Pablo J, Tyndale RF, Ervin FD, Williams IC, Singleton EG, Mayor M. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Annals of the New York Academy of Sciences. 914: 394-401. PMID 11085338 DOI: 10.1111/J.1749-6632.2000.Tb05213.X |
0.536 |
|
| 2000 |
Baumann MH, Pablo JP, Ali SF, Rothman RB, Mash DC. Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine. Annals of the New York Academy of Sciences. 914: 354-68. PMID 11085335 DOI: 10.1111/J.1749-6632.2000.Tb05210.X |
0.557 |
|
| 1999 |
Zubaran C, Shoaib M, Stolerman IP, Pablo J, Mash DC. Noribogaine generalization to the ibogaine Stimulus: Correlation with noribogaine concentration in rat brain Neuropsychopharmacology. 21: 119-126. PMID 10379526 DOI: 10.1016/S0893-133X(99)00003-2 |
0.53 |
|
| 1999 |
Basile DV, Punch MS, Pablo J, Brenner B, Hearn WL, Mash DC. Indole alkaloids from tissue-cultured Tabernanthe iboga H. Bn Natural Product Letters. 13: 233-238. DOI: 10.1080/10575639908048791 |
0.494 |
|
| 1998 |
Pablo JP, Mash DC. Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding. Neuroreport. 9: 109-14. PMID 9592058 DOI: 10.1097/00001756-199801050-00022 |
0.52 |
|
| 1996 |
Staley JK, Ouyang Q, Pablo J, Hearn WL, Flynn DD, Rothman RB, Rice KC, Mash DC. Pharmacological screen for activities of 12-hydroxyibogamine: A primary metabolite of the indole alkaloid ibogaine Psychopharmacology. 127: 10-18. PMID 8880938 DOI: 10.1007/Bf02805969 |
0.571 |
|
| 1995 |
Hearn WL, Pablo J, Hime GW, Mash DC. Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. Journal of Analytical Toxicology. 19: 427-34. PMID 8926737 DOI: 10.1093/Jat/19.6.427 |
0.474 |
|
| 1995 |
Mash DC, Staley JK, Pablo JP, Holohean AM, Hackman JC, Davidoff RA. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neuroscience Letters. 192: 53-6. PMID 7675310 DOI: 10.1016/0304-3940(95)11608-Y |
0.507 |
|
| 1991 |
Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice Experimental Neurology. 114: 73-81. PMID 1915737 DOI: 10.1016/0014-4886(91)90086-R |
0.529 |
|
| 1990 |
Mash DC, Pablo J, Flynn DD, Efange SMN, Weiner WJ. Characterization and distribution of transferrin receptors in the rat brain Journal of Neurochemistry. 55: 1972-1979. PMID 2230804 DOI: 10.1111/J.1471-4159.1990.Tb05784.X |
0.528 |
|
| 1990 |
Efange SM, Kung HF, Mash DC, Jabir M, Billings J, Pablo J, Dutta A, Freshler A. Pargyline-sensitive selective accumulation of a radiolabeled MPTP analog in the primate cerebral cortex and basal ganglia. Synapse (New York, N.Y.). 5: 207-12. PMID 2111588 DOI: 10.1002/Syn.890050306 |
0.527 |
|
| Show low-probability matches. |